Linezolid 2 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

linezolid 2 mg/ml solution for infusion

mcdermott laboratories ltd., t/a gerard laboratories - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid

Regiocit Solution for Haemofiltration Malta - English - Medicines Authority

regiocit solution for haemofiltration

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, sodium citrate - solution for haemofiltration - sodium chloride 5.03 g/l sodium citrate 5.29 g/l sodium 140 mmol/l chloride 86 mmol/l - blood substitutes and perfusion solutions

GADOVIST 1.0 gadobutrol 1.2094 g/2 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

gadovist 1.0 gadobutrol 1.2094 g/2 ml solution for injection vial

bayer australia ltd - gadobutrol, quantity: 604.72 mg/ml - injection, solution - excipient ingredients: calcobutrol sodium; trometamol; hydrochloric acid; water for injections - this medicinal product is for diagnostic use only. gadovist 1.0 is indicated in adults and children including full-term newborns for: ? contrast enhancement in cranial and spinal magnetic resonance imaging (mri) ? contrast enhancement in whole body mri including head and neck region, thoracic space, breast, abdomen (pancreas, liver and spleen), pelvis (prostate, bladder and uterus), retroperitoneal space (kidney), extremities and musculoskeletal system ? use in first?pass mri studies of cerebral perfusion (see precautions) ? contrast enhancement in magnetic resonance angiography (ce mra) (see clinical trials) ? contrast enhancement in cardiac mri including assessment of rest and pharmacological stress perfusion and delayed enhancement